Literature DB >> 12757848

Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses.

Stefan I Liochev1, Irwin Fridovich.   

Abstract

FALS-associated missense mutations of SOD1 exhibit a toxic gain of function that leads to the death of motor neurons. The explanations for this toxicity fall into two broad categories. One involves a gain of some oxidative activity, while the second involves a gain of protein: protein interactions. Among the postulated oxidative activities are the following: (i) peroxidase action; (ii) superoxide reductase action; and, (iii) the enhancement of production of O2- by partial reversal of the normal SOD activity, which then leads to increased formation of ONOO(-). We will herein concentrate on evaluating the relative merits of these oxidative hypotheses and consider whether the experiments with transgenic animals that purport to disprove these oxidative explanations really do so.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757848     DOI: 10.1016/s0891-5849(03)00153-9

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  25 in total

Review 1.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

2.  Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice.

Authors:  Yoshiaki Furukawa; Ronggen Fu; Han-Xiang Deng; Teepu Siddique; Thomas V O'Halloran
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

3.  Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.

Authors:  Han-Xiang Deng; Yong Shi; Yoshiaki Furukawa; Hong Zhai; Ronggen Fu; Erdong Liu; George H Gorrie; Mohammad S Khan; Wu-Yen Hung; Eileen H Bigio; Thomas Lukas; Mauro C Dal Canto; Thomas V O'Halloran; Teepu Siddique
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

4.  Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses.

Authors:  Wayne Chadwick; Yu Zhou; Sung-Soo Park; Liyun Wang; Nicholas Mitchell; Matthew D Stone; Kevin G Becker; Bronwen Martin; Stuart Maudsley
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

Review 5.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

6.  Neuropathic pain modifies antioxidant activity in rat spinal cord.

Authors:  Renata P Guedes; Lidiane Dal Bosco; Camila M Teixeira; Alex S R Araújo; Susana Llesuy; Adriane Belló-Klein; Maria Flávia M Ribeiro; Wania A Partata
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

7.  The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis.

Authors:  Lijun Wang; Kamal Sharma; Gabriella Grisotti; Raymond P Roos
Journal:  Neurobiol Dis       Date:  2009-05-12       Impact factor: 5.996

Review 8.  ER stress and unfolded protein response in amyotrophic lateral sclerosis.

Authors:  Kohsuke Kanekura; Hiroaki Suzuki; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2009-01-30       Impact factor: 5.590

9.  Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice.

Authors:  Kevin Chen; Frances J Northington; Lee J Martin
Journal:  Brain Struct Funct       Date:  2009-11-04       Impact factor: 3.270

10.  The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.

Authors:  Lee J Martin; Barry Gertz; Yan Pan; Ann C Price; Jeffery D Molkentin; Qing Chang
Journal:  Exp Neurol       Date:  2009-03-09       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.